Skip to main content

Advertisement

SpringerLink
Log in

Hypertension and heart failure: Diagnosis and management

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Heart failure continues to be a significant problem faced by today’s health care professional. Heart failure remains one of the principal causes of cardiovascular morbidity and mortality. The prevalence of heart failure continues to increase, largely due to an aging population and to modern technologic innovations that have led to prolonged survival of the cardiac patient. Hypertension increases the risk for heart failure in all age groups. In those individuals aged 40 years or older whose blood pressure is > 140/90 mm Hg, the lifetime risk for developing heart failure may be twice as high as that of their aged-matched counterparts. Therefore, it is imperative that the clinician be aware of the current diagnostic and therapeutic advancements for the early detection and aggressive treatment of hypertension and heart failure, to prevent patients from developing symptoms of heart failure and to decrease the need for hospitalizations once the diagnosis is confirmed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. American Heart Association: Heart Disease and Stroke Statistics 2004 Update. Dallas, TX: American Heart Association; 2003.

    Google Scholar 

  2. Mehra MR, Uber PA, Potluri S, Ventura O: Is heart failure with preserved systolic function an overlooked enigma? Curr Cardiol Rep 2002, 4:187–193.

    PubMed  Google Scholar 

  3. Senni M, Redfield MM: Heart failure with preserved systolic function. A different natural history? J Am Coll Cardiol 2001, 38:1277–1282.

    Article  PubMed  CAS  Google Scholar 

  4. Vasan RS, Larson MG, Benjamin EJ, et al.: Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999, 33:1948–1955.

    Article  PubMed  CAS  Google Scholar 

  5. Vasan RS, Benjamin EJ, Levy D: Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995, 26:1565–1574.

    Article  PubMed  CAS  Google Scholar 

  6. Redfield MN, Jacobsen SJ, Burnett JC, et al.: Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of heart failure epidemic. JAMA 2003, 289:194–202. Excellent epidemiologic paper on the burden of heart failure on the community.

    Article  PubMed  Google Scholar 

  7. Senni M, Tribouilloy CM, Rodeheffer RJ, et al.: Congestive heart failure in the community: trends in incidence and survival in a 10-year period. Arch Intern Med 1999, 159:29–34.

    Article  PubMed  CAS  Google Scholar 

  8. Vasan RS, Benjamin EJ, Levy D: Congestive heart failure with normal left ventricular systolic function: clinical approaches to the diagnosis and treatment of diastolic heart failure. Arch Inter Med 1996, 156:146–157.

    Article  CAS  Google Scholar 

  9. Slama M, Susic D, Varagic J, et al.: Diastolic dysfunction in hypertension. Curr Opin Cardiol 2002, 17:368–373.

    Article  PubMed  Google Scholar 

  10. Lloyd-Jones DM, Larson MG, Leip EP, et al.: Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002; 106:3068–3072.

    Article  PubMed  Google Scholar 

  11. He J, Ogden LG, Bazzano LA, et al.: Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 2001, 161:996–1002.

    Article  PubMed  CAS  Google Scholar 

  12. Kannel WB, Ho K, Thom T: Changing epidemiological features of cardiac failure. Br Heart J 1994; 72:S3-S9.

    PubMed  CAS  Google Scholar 

  13. Mandinov L, Eberli FR, Seiler C, et al.: Diastolic heart failure. Cardiovasc Res 2000, 45:813–825.

    Article  PubMed  CAS  Google Scholar 

  14. Frohlich ED: Risk mechanisms in hypertensive heart disease. Hypertension 1999, 34:782–789.

    PubMed  CAS  Google Scholar 

  15. Fouad-Tarazi FM: Left ventricular diastolic dysfunction in hypertension. Curr Opin Cardiol 1994, 9:551–560.

    Article  PubMed  CAS  Google Scholar 

  16. Ventura HO, Loyalka P, Smart FW: Treatment of the hypertensive patient with microvascular angina. Curr Opin Cardiol 1999, 14:370–374.

    Article  PubMed  CAS  Google Scholar 

  17. Cohn JN, Johnson G: Heart failure with normal ejection fraction. The V-HeFT Study. Veterans Administration Cooperative Study Group. Circulation 1990, 81:48–53.

    Google Scholar 

  18. Dunlap SH, Sueta CA, Adams KF: Association of body mass, gender, race with heart failure primarily due to hypertension. J Am Coll Cardiol 1999, 34:1602–1608.

    Article  PubMed  CAS  Google Scholar 

  19. Laurent D: Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. Am J Physiol 1987, 252:C1-C9.

    PubMed  CAS  Google Scholar 

  20. Moncrieff J, Lindsay M, Dunn F: Hypertensive heart disease and fibrosis. Curr Opin Cardiol 2004, 19:326–331.

    Article  PubMed  Google Scholar 

  21. Redfield MM, Jacobsen SJ, Burnett JC, et al.: Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003, 289:194–202.

    Article  PubMed  Google Scholar 

  22. Levy D, Labib SB, Anderson KM, et al.: Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation 1990, 81:815–820.

    PubMed  CAS  Google Scholar 

  23. Otto C: Textbook of Clinical Echocardiography, edn 3. Philadelphia: Elsevier/Saunders; 2004.

    Google Scholar 

  24. Krishnaswamy P, Lubien E, Clopton P, et al.: Utility of Bnatriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med 2001, 111:274–279.

    Article  PubMed  CAS  Google Scholar 

  25. Lubien E, DeMaria A, Krishnaswamy P, et al.: Utility of B-natriuretic peptide levels in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002, 105:595–601.

    Article  PubMed  CAS  Google Scholar 

  26. The SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991, 325:303–310.

  27. Pfeffer MA, Braunwald E, Moye LA, et al.: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE investigators. N Engl J Med 1992, 327:669–677.

    Article  PubMed  CAS  Google Scholar 

  28. Packer M, Bristow MR, Cohn JN, et al.: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. The US Carvedilol Heart Failure Study Group. N Engl J Med 1996, 334:1349–1355.

    Article  PubMed  CAS  Google Scholar 

  29. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999, 353:9–13.

  30. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999, 353:2001–2007.

  31. McMurray JJ, Ostergren J, Swedberg K, et al.: Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARMAdded trial. Lancet 2003, 362:767–771.

    Article  PubMed  CAS  Google Scholar 

  32. Pitt B, Zannad F, Remme WJ, et al.: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999, 341:709–717.

    Article  PubMed  CAS  Google Scholar 

  33. Pitt B, Remme W, Zannad F, Neaton J: Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348:1309–1321.

    Article  PubMed  CAS  Google Scholar 

  34. Taylor AL, Ziesche S, Yancy C, et al.: Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. The African-American Heart Failure trial Investigators. N Engl J Med 2004, 351:2049–2057.

    Article  PubMed  CAS  Google Scholar 

  35. Schmieder RE, Martus P, Klingbeil A: Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA 1996, 275:1507–1513.

    Article  PubMed  CAS  Google Scholar 

  36. Ventura HO, Loyalka P, Smart FW: Treatment of the hypertensive patient with microvascular angina. Curr Opin Cardiol 1999, 14:370–374.

    Article  PubMed  CAS  Google Scholar 

  37. Poulsen SH, Jensen SE, Egstrup K: Effects of long-term adrenergic beta-blockade on left ventricular diastolic filling in patients with acute myocardial infarction. Am Heart J 1999, 138:710–720.

    Article  PubMed  CAS  Google Scholar 

  38. Matsubara LS, Matsubara BB, Okoshi MP, et al.: Alterations in myocardial collagen content affect rat papillary muscle function. Am J Physiol Heart Circ Physiol 2000, 279:H1534-H1539.

    PubMed  CAS  Google Scholar 

  39. Warner JG Jr, Metzger DC, Kitzman DW, et al.: Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol 1999, 33:1567–1572.

    Article  PubMed  CAS  Google Scholar 

  40. Diez J, Querejeta R, Lopez B, et al.: Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 2002, 105:2512–2517.

    Article  PubMed  CAS  Google Scholar 

  41. Dahlof B, Devereux RB, Kjeldsen SE, et al.: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint Reduction in Hypertension Study (LIFE): a randomised trial against atenolol. Lancet 2002, 359:995–1003.

    Article  PubMed  CAS  Google Scholar 

  42. Yusuf S, Pfeffer MA, Swedberg K, et al.: Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved trial. Lancet 2003, 362:777–781. The most impressive data to date with regard to treatment of heart failure with preserved systolic function.

    Article  PubMed  CAS  Google Scholar 

  43. Setaro JF, Zaret BL, Schulman DS, et al.: Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol 1990, 66:981–986.

    Article  PubMed  CAS  Google Scholar 

  44. Terpstra WF, May JF, Smit AJ, et al.: Long term effects of amlodipine and lisinopril on left ventricular mass and diastolic dysfunction in the elderly, in previously treated hypertensive patients: the ELVERA trial. J Hypertens 2001, 19:303–309.

    Article  PubMed  CAS  Google Scholar 

  45. Hopf R, Kaltenbach M: Ten-year results and survival of patients with hypertrophic cardiomyopathy treated with calcium antagonists. Z Kardiol 1987, 76:137–144.

    PubMed  Google Scholar 

  46. Bonow RO, Dilsizian V, Rosing DR, et al.: Verapamilinduced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects. Circulation 1985, 72:853–864.

    PubMed  CAS  Google Scholar 

  47. Hunt SA, Abraham WT, Chin M, et al.: ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult. J Am Coll Cardiol 2005, 46:1–82.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Ochsner Clinic Foundation, 1514 Jefferson Highway, 70121, New Orleans, LA, USA

    Hector O. Ventura MD

Authors
  1. Kevin A. Courville MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hector O. Ventura MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hector O. Ventura MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Courville, K.A., Ventura, H.O. Hypertension and heart failure: Diagnosis and management. Current Science Inc 8, 185–190 (2006). https://doi.org/10.1007/s11906-006-0049-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-006-0049-0

Keywords

Search

Navigation